Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 5, 2018

NeuroPace launches new RNS System to treat refractory epilepsy

US-based medical technology company NeuroPace has launched the new Next Gen RNS System to treat seizures in patients suffering from refractory epilepsy.

US-based medical technology company NeuroPace has launched its Next Gen RNS System to treat seizures in patients suffering from refractory epilepsy.

The next generation system is designed as a closed loop brain-responsive neurostimulation device based on a brain-computer interface that can continuously monitor brain waves.

It identifies the ‘seizure onset fingerprint’ unique to individual patients and automatically sends imperceptible electrical pulses even before the occurrence of seizures.

“The RNS System consists of a neurostimulator, a remote monitor for patients to upload their data and a RNS Tablet.”

In its new device, NeuroPace increased battery life from 3.9 years to 8.4 years under medium stimulation environments, to ensure fewer interruptions for patients.

The Next Gen RNS System also features additional memory to enable review of more brain activity data.

NeuroPace CEO Frank Fischer said: “NeuroPace revolutionised epilepsy therapy in 2013 with the introduction of the world’s first closed loop, brain-responsive neuromodulation system-the only device that applies brain-computer interface technology to successfully treat refractory focal onset epilepsy.

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment

“We have maintained our relentless focus on product innovation, and are excited to make the Next Gen RNS System with twice the longevity and twice the memory in the same size device available to our physician customers and their patients.”

The RNS System consists of a neurostimulator, a remote monitor for patients to upload their data and a RNS Tablet.

It is accompanied by a Patient Data Management System (PDMS) for physicians to remotely track patient’s electrographic data and programme the device to personalise therapy based on individual brain patterns.

The system is an adjunctive therapy for adults with refractory, focal onset seizures with not more than two epileptogenic foci.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU